GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
100 hedge funds and large institutions have $699M invested in G1 Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 38 increasing their positions, 26 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 16
14% less call options, than puts
Call options by funds: $231K | Put options by funds: $269K
Holders
100
Holding in Top 10
2
Calls
$231K
Puts
$269K
Top Buyers
| 1 | +$12.4M | |
| 2 | +$8.49M | |
| 3 | +$3.43M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$3.43M |
| 5 |
BlackRock
New York
|
+$2.54M |
Top Sellers
| 1 | -$9.05M | |
| 2 | -$6.05M | |
| 3 | -$4.54M | |
| 4 |
Morgan Stanley
New York
|
-$2.65M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
-$1.87M |